• 1. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

Professional Introduction to 3-bromo-5-fluoro-N-methylpyridin-2-amine (CAS No. 2385124-34-3)

3-bromo-5-fluoro-N-methylpyridin-2-amine is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. With the CAS number 2385124-34-3, this compound represents a critical intermediate in the synthesis of various biologically active molecules. Its unique structural features, including the presence of both bromo and fluoro substituents, make it a valuable building block for developing novel therapeutic agents.

The< strong>3-bromo-5-fluoro-N-methylpyridin-2-amine molecule is characterized by a pyridine core, which is a common scaffold in many pharmacologically relevant compounds. The bromo and fluoro groups introduce specific electronic and steric properties that can be exploited in drug design. For instance, the bromine atom can serve as a handle for further functionalization via cross-coupling reactions, while the fluorine atom is known for its ability to modulate metabolic stability and binding affinity.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting various disease pathways. The< strong>3-bromo-5-fluoro-N-methylpyridin-2-amine compound has been extensively studied as a precursor in the synthesis of kinase inhibitors, particularly those targeting tyrosine kinases involved in cancer therapy. The pyridine ring's ability to interact with aromatic pockets in protein targets makes it an ideal candidate for designing selective inhibitors.

One of the most compelling aspects of< strong>3-bromo-5-fluoro-N-methylpyridin-2-amine is its role in the development of next-generation antiviral agents. The fluoro substituent, in particular, has been shown to enhance the pharmacokinetic properties of antiviral drugs by improving their resistance profile against enzymatic degradation. This has led to several innovative drug candidates being explored in clinical trials, with promising results in treating viral infections.

The< strong>2385124-34-3 compound's versatility extends beyond its applications in oncology and virology. It has also been utilized in the synthesis of central nervous system (CNS) drugs, where its ability to cross the blood-brain barrier is highly advantageous. Researchers have leveraged its structural motif to develop novel compounds with potential therapeutic effects in neurodegenerative disorders such as Alzheimer's and Parkinson's disease.

The synthesis of< strong>3-bromo-5-fluoro-N-methylpyridin-2-amine involves multi-step organic transformations that highlight the compound's synthetic utility. The bromination and fluorination steps are particularly well-studied, with recent advances in catalytic methods allowing for higher yields and selectivity. These improvements have not only streamlined the production process but also opened up new avenues for derivative synthesis.

In conclusion, the< strong>3-bromo-5-fluoro-N-methylpyridin-2-amine (CAS No. 2385124-34-3) is a cornerstone compound in modern medicinal chemistry. Its unique structural attributes and broad applicability make it indispensable in the quest for novel therapeutic interventions. As research continues to uncover new biological targets and mechanisms, this compound will undoubtedly play a pivotal role in shaping the future of drug discovery and development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)